PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer

NEOSTAR Phase II platform trial demonstrates neoadjuvant immunotherapy combinations can enhance treatment responses in operable NSCLC

Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer
2023-03-16
(Press-News.org) HOUSTON ― In a Phase II trial led by researchers from The University of Texas MD Anderson Cancer Center, adding ipilimumab to a neoadjuvant, or pre-surgical, combination of nivolumab plus platinum-based chemotherapy, resulted in a major pathologic response (MPR) in half of all treated patients with early-stage, resectable non-small cell lung cancer (NSCLC).

New findings from the NEOSTAR trial, published today in Nature Medicine, provide further support for neoadjuvant immunotherapy-based treatment as an approach to reduce viable tumor at surgery and to improve outcomes in NSCLC. The combination also was associated with an increase in immune cell infiltration and a favorable gut microbiome composition.

The current study reports on the latest two arms of the NEOSTAR trial, evaluating neoadjuvant nivolumab plus chemotherapy (double combination) and neoadjuvant ipilimumab plus nivolumab and chemotherapy (triple combination). Both treatment arms met their prespecified primary endpoint boundaries of six or more patients achieving MPR, defined as 10% or less residual viable tumor (RVT) in the resected tumor specimen at surgery, a candidate surrogate endpoint of improved survival outcomes from prior studies.

In the intention-to-treat population, the triple combination resulted in an MPR rate of 50%, whereas 32.1% of patients achieved MPR after double combination treatment. Both treatment arms also exceeded the historical MPR rates of 15% achieved by neoadjuvant chemotherapy alone.

“The results we see with neoadjuvant dual immunotherapy and chemotherapy are very encouraging,” said corresponding author Tina Cascone, M.D., Ph.D., assistant professor of Thoracic/Head & Neck Medical Oncology. “This is a population of patients that can potentially be cured, but they need more effective treatment strategies to reduce their risk of disease relapse and improve their outcomes. The NEOSTAR platform provides us with a quick readout of potentially effective regimens and allows us to perform translational analyses and correlative research work before and after treatment.”

Among patients diagnosed with NSCLC, roughly 30% have potentially resectable disease, meaning their tumor can be surgically removed. While many of these patients can potentially be cured with surgery, it is estimated that more than half will have a recurrence without additional therapy. Unfortunately, chemotherapy given either before or after surgery provides only a minimal survival benefit. Previous reports from the NEOSTAR trial demonstrated that neoadjuvant nivolumab plus ipilimumab induced higher MPR rates relative to historical controls of chemotherapy and nivolumab alone and resulted in greater immunological memory relative to nivolumab monotherapy.

Triple combination reduces viable tumor, enhances markers of immune activation
Each arm enrolled 22 patients with surgically resectable stage IB to IIIA NSCLC between December 2018 and December 2020. In the double combination arm, participants were 86% White, 14% Asian, and 45% male; in the triple combination arm, participants were 82% White, 5% Asian, 14% Black, and 68% male.

The NEOSTAR trial was not designed for direct comparisons between arms, but an exploratory analysis of clinical and pathological findings showed that adding a single dose of ipilimumab resulted in an increase in beneficial tumor immune cell infiltration and reduced RVT at surgery.

Patients treated with the triple combination had a median of 4.5% RVT at surgery, compared to 50.5% RVT in patients treated with the double combination. All patients achieving MPR in the triple combination cohort and 86% of those achieving MPR in the double combination cohort had less than 5% RVT at surgery. All patients treated with the double combination and 91% of those treated with the triple combination underwent surgery. No new safety signals were observed in both treatment arms.

Further analyses showed treatment with the triple combination resulted in an increase in tumor-infiltrating lymphocytes – including subtypes of CD8+ T cells and B cells and in markers of specialized immune cell clusters called tertiary lymphoid structures, as well as reduced infiltration of immunosuppressive cells, all of which can be signs of enhanced anti-tumor response.

Upon analyzing the gut microbiome in patients who achieved MPR, the researchers found an enrichment in beneficial bacteria previously associated with favorable responses to immunotherapy in lung cancer, melanoma and other cancer types, along with reduced abundance of potentially pathogenic microbes.

NEOSTAR platform is an effective strategy to rapidly test neoadjuvant therapies
Interestingly, an exploratory comparison indicates some results from the double combination arm of the NEOSTAR trial are similar overall to those seen in the recent Checkmate-816 trial. This global randomized Phase III study evaluated neoadjuvant nivolumab plus chemotherapy compared to chemotherapy alone in patients with resectable NSCLC, and results from the study led to the first FDA-approved neoadjuvant therapy for NSCLC.

Both Checkmate-816 and NEOSTAR showed similar overall MPR rates and event-free survival benefits from adding neoadjuvant nivolumab to chemotherapy. The similarity between the two trials suggests that the NEOSTAR platform may offer a viable strategy to rapidly evaluate neoadjuvant therapies.

“The modular platform of the NEOSTAR trial provides an opportunity to test promising regimens and quickly make a ‘go’ or ‘no-go’ decision,” Cascone said. “This trial is an incredible testament to the team science environment at MD Anderson. Our clinical and multi-omics analyses were made possible through collaborative efforts from clinicians, surgeons, pathologists, scientists, bioinformaticians and statisticians across several departments looking at many features of these patients and their tumors and other samples. Thanks to their incredible work, we are able to rapidly generate results that could guide the next generation of trials to further improve patient outcomes.”

The results of these latest two arms of the study support the addition of neoadjuvant CTLA-4 blockade to nivolumab plus chemotherapy prior to NSCLC resection for improving outcomes and suggest that this combination merits further investigation.

The NEOSTAR trial was supported by the Bristol-Myers Squibb Company. Additional research support was provided by Lung Cancer Moon Shot®, part of MD Anderson’s Moon Shots Program®, the National Institute of Health/National Cancer Institute (5P50CA070907, P30 CA016672, 1S10OD024977-01 award, T32CA217789, R01CA248731, R01CA262425), the American Society of Clinical Oncology’s Conquer Cancer Foundation Career Development Award, the Andrew Sabin Family Foundation, the Connie Rasor Endowment for Cancer Research, David Bruton, Jr. Chair, the Translation Molecular Profiling Immuno-profiling Laboratory, the MD Anderson Physician Scientist Program, the Khalifa Bin Zayed Al Nahyan Foundation, Rexanna’s Foundation for Fighting Lung Cancer and the Bob Mayberry Foundation. A full list of co-authors and author disclosures can be found here.

- 30 -

END


[Attachments] See images for this press release:
Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer

ELSE PRESS RELEASES FROM THIS DATE:

How fishermen benefit from reversing evolution of cod

How fishermen benefit from reversing evolution of cod
2023-03-16
Leipzig. Intense fishing and overexploitation have led to evolutionary changes in fish stocks like cod, reducing both their productivity and value on the market. These changes can be reversed by more sustainable and far-sighted fisheries management. The new study by researchers from the German Centre for Integrative Biodiversity Research (iDiv), Leipzig University and the Institute of Marine Research in Tromsø, which was published in Nature Sustainability, shows that reversal of evolutionary change would only slightly reduce the profit of fishing, but would help regain and conserve natural genetic diversity. The impact of global fisheries on marine ecosystems ...

Displays with more brilliant colors through a fundamental physical concept

2023-03-16
A research team from the University of Cologne (Germany) and the University of St Andrews (Scotland) has shown in a new study how a fundamental physical concept can be used to boost the colour brilliance of smartphone, computer or TV screens without cutbacks in energy efficiency. The results have been published in Nature Photonics. Organic light-emitting diodes (OLEDs) have conquered the market for displays in recent years – from high-resolution smartphone to wall-sized television screens. However, industry and science face several challenges in creating the next generation of devices ...

Hot topic – how heat flow affects the Earth’s magnetic field

2023-03-16
Hot topic – how heat flow affects the Earth’s magnetic field  Compass readings that do not show the direction of true north and interference with the operations of satellites are a few of the problems caused by peculiarities of the Earth’s magnetic field.  The magnetic field radiates around the world and far into space, but it is set by processes that happen deep within the Earth’s core, where temperatures exceed 5,000-degress C.  New research from geophysicists at the University of Leeds suggests that ...

Case report of first mixed race woman possibly cured of HIV published in Cell

2023-03-16
A new method to cure HIV—by transplanting HIV-resistant stem cells from umbilical cord blood—has yielded long-term successful results, say scientists. The approach was successfully used to treat the “New York patient,” a middle-aged woman with leukemia and HIV who self-identifies as mixed race, who has been without HIV since 2017. Using stem cells from cord blood rather than from compatible adult donors, as has been done previously, increases the potential to cure HIV via stem cell transplantation ...

Genomic analysis shows the Amazon’s Ashaninka people are made up of two subgroups with distinct histories

Genomic analysis shows the Amazon’s Ashaninka people are made up of two subgroups with distinct histories
2023-03-16
The Ashaninka are the most numerous Indigenous people living in the rainforests of Peru and Brazil where they inhabit a crucial area between the Andes and sources of the Amazon River. And yet, despite the size of the population and their importance in the past and present, their genetic history has remained understudied. Now a team of researchers reporting in the journal Current Biology on March 16 has analyzed the genomes of more than 50 individuals to clarify the group’s interactions with nearby South American regions, including Central America and the Caribbean. ...

Indigenous Ashaninka DNA helps geneticists write new chapters of pre-colonial history in South America

2023-03-16
Geneticists have written new chapters in the reconstruction of pre-colonial Americas history after using DNA from the indigenous Ashaninka people from Amazonian Peru. They have discovered previously unexpected levels of genetic variation in this group and uncovered a strong hint that these people were involved in a South-to-North migration that led to the transition from an archaic to ceramic culture in the Caribbean islands.  The dramatic impact of European colonisation during the second half of the last millennium has strongly influenced the genetic history of the Americas, making the reconstruction ...

Financial hardship and employment loss among adults with disabilities during COVID-19

2023-03-16
About The Study: This survey study found that people with disabilities were more likely to report household employment loss and financial hardship during the initial COVID-19 pandemic, which are especially pronounced among racial and ethnic minority respondents. These findings suggest people with disabilities may be disproportionately affected by the initial pandemic and may require additional resources and policy strategies (e.g., training programs, workplace accommodations) as several labor markets adapt to the pandemic (e.g., shifting to remote working).  Authors: Kea Turner, Ph.D., M.P.H., M.A., of the H. Lee Moffitt Cancer Center ...

Readmission rates, episode costs for Alzheimer disease and related dementias

2023-03-16
About The Study: In this study of 722,000 hospitalization episodes, patients with Alzheimer disease and related dementias (ADRD) had higher readmission rates and overall readmission and episode costs than their counterparts without ADRD. Hospitals may need to be better equipped to care for patients with ADRD, especially in the post-discharge period. Considering that any type of hospitalization may put patients with ADRD at a high risk of 30-day readmission, judicious preoperative assessment, postoperative discharge, and ...

Preterm babies do not habituate to repeated pain

2023-03-16
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study led by UCL (University College London) researchers. The authors of the new Current Biology paper say that if preterm infants have not yet developed the mechanism that enables people to get used to moderate pain, medical procedures in their first few weeks of life could potentially impact their development. Lead author Dr Lorenzo Fabrizi (UCL Neuroscience, Physiology & Pharmacology) said: “The way that we can get used to things can be seen as the simplest example of behavioural and brain plasticity, and it is ...

Compressive stress shapes the symmetry of Arabidopsis root vascular tissue

Compressive stress shapes the symmetry of Arabidopsis root vascular tissue
2023-03-16
Ikoma, Japan – The generation and maintenance of tissue boundaries are fundamental to the development of functional organs in both plants and animals. In general, tissue boundaries are initially set among primordial cells, and their shapes and arrangements are refined during subsequent organ growth. In this process, cell migration plays a curtail role for boundary refinement in animal systems, however, plant tissue lacks such cell fluidity due to its cell walls. Despite significant progress in understanding the initial patterning of tissue boundaries in several ...

LAST 30 PRESS RELEASES:

12.5, the 1st Impact Factor of COMMTR released!

Circadian clock impact on cluster headaches funded by $2.4M NIH grant for UTHealth Houston research

Study identifies first drug therapy for sleep apnea

How old is your bone marrow?

Boosting biodiversity without hurting local economies

ChatGPT is biased against resumes with credentials that imply a disability — but it can improve

Simple test for flu could improve diagnosis and surveillance

UT Health San Antonio researcher awarded five-year, $2.53 million NIH grant to study alcohol-assisted liver disease

Giving pre-med students hands-on clinical training

CAMH research suggests potential targets for prevention and early identification of psychotic disorders

Mapping the heart to prevent damage caused by a heart attack

Study challenges popular idea that Easter islanders committed ‘ecocide’

Chilling discovery: Study reveals evolution of human cold and menthol sensing protein, offering hope for future non-addictive pain therapies.

Elena Beccalli, new rector of Università Cattolica del Sacro Cuore, takes office on 1st July

Pacific Northwest Research Institute uncovers hidden DNA mechanisms of rare genetic diseases

Empowering older adults: Wearable tech made easier with personalized support

Pennington Biomedical researchers partner on award-winning Long Covid study

Cooling ‘blood oranges’ could make them even healthier – a bonus for consumers

Body image and overall health found important to the sexual health of older gay men, according to new studies

Lab-grown muscles reveal mysteries of rare muscle diseases

Primary hepatic angiosarcoma: Treatment options for a rare tumor

Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementia

Navigating the Pyrocene: Recent Cell Press papers on managing fire risk

Restoring the Great Salt Lake would have environmental justice as well as ecological benefits

Cannabis, tobacco use, and COVID-19 outcomes

A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes

Scientists document self-propelling oxygen decline in the oceans

Activating molecular target reverses multiple hallmarks of aging

Cannabis use tied to increased risk of severe COVID-19

How to make ageing a ‘fairer game’ for all wormkind

[Press-News.org] Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer
NEOSTAR Phase II platform trial demonstrates neoadjuvant immunotherapy combinations can enhance treatment responses in operable NSCLC